Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all

NCT05514912 2023-12-26

Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma

NCT02392637 2022-02-02

Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers

Phase 2 Completed

62 enrolled 10 charts

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma